FindTrial
Sign In

Effect of Transcranial Direct Current Stimulation (tDCS) on Improving Inhibitory Control and Working Memory in Children with Attention-Deficit / Hyperactivity Disorder (ADHD) and comorbid Autism Spectrum Disorder (ASD) – A Randomised Controlled Trial

Effect of Transcranial Direct Current Stimulation (tDCS) on Improving Inhibitory Control and Working Memory in Children with Attention-Deficit / Hyperactivity Disorder (ADHD) and comorbid Autism Spectrum Disorder (ASD) – A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056203
Enrollment
Unknown
Registered
2022-02-01
Start date
2021-10-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorde (ADHD), Autism Spectrum Disorder (ASD)

Interventions

Intervention group:tDCS
Control group:sham stimulation

Sponsors

nil
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Age of 6 - 12 years old; 2. Right-handed 3. With a diagnosis of ADHD and comorbid ASD made based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) by a Psychiatry specialist; 4. Able to understand spoken instructions in Cantonese and read written traditional Chinese; 5. Studying in mainstream school; 6. Currently not taking stimulant medications (Methylphenidate or Lisdexamfetamine), or agree to stop stimulant medications starting from 72 hours before the first stimulation and until one week after the last stimulation.

Exclusion criteria

Exclusion criteria: 1. History of significant head trauma or skull defects; 2. Implanted with pacemakers, intracranial electrodes, defibrillators, or other metallic implants; 3. Neurological conditions including but not limited to seizure, stroke, intracranial tumors or aneurysms; 4. Sensory or motor impairments; 5. Documented history of Intellectual Disability; 6. Currently on psychotropics other than stimulants or other CNS drugs

Design outcomes

Primary

MeasureTime frame
Computerized Neurocognitive Battery;—

Countries

China

Contacts

Public ContactOr Parr Ning Brian

The Chinese University of Hong Kong

brianor@cuhk.edu.hk+852 26076026

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026